Evidence map›Paper›PMID 29026654›Full record

ArticleMicrobial genomics2017

Population genetic structuring of methicillin-resistant

Tjibbe Donker, Sandra Reuter, James Scriberras, Rosy Reynolds, Nicholas M Brown, M Estée Török, Richard James, East Of England Microbiology Research Network, David M Aanensen, Stephen D Bentley and 6 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. CharacterizingmSystems · 2025
    Article
  4. Article
  5. Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Tjibbe Donker2​Department of Medical Microbiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Sandra Reuter3​Department of Medicine, University of Cambridge, Cambridge, UK.
James Scriberras5​The Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath, UK.
Rosy Reynolds6​British Society for Antimicrobial Chemotherapy, UK.
Nicholas M Brown6​British Society for Antimicrobial Chemotherapy, UK.
M Estée Török3​Department of Medicine, University of Cambridge, Cambridge, UK.
Richard James10​Department of Physics and Centre for Networks and Collective Behaviour, University of Bath, Bath, UK.
East Of England Microbiology Research Network11​East of England Microbiology Research Network, UK.
David M Aanensen12​Faculty of Medicine, School of Public Health, Imperial College, London, UK.
Stephen D Bentley4​Pathogen Genomics, Wellcome Trust Sanger Institute, Hinxton, UK.
Matthew T G Holden4​Pathogen Genomics, Wellcome Trust Sanger Institute, Hinxton, UK.
Julian Parkhill4​Pathogen Genomics, Wellcome Trust Sanger Institute, Hinxton, UK.
Brian G Spratt12​Faculty of Medicine, School of Public Health, Imperial College, London, UK.
Sharon J Peacock3​Department of Medicine, University of Cambridge, Cambridge, UK.
Edward J Feil5​The Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath, UK.
Hajo Grundmann2​Department of Medical Microbiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
University of Cambridge · GBUniversity Medical Center Groningen · NLUniversity of Bath · GBUniversity of St Andrews · GBWellcome Sanger Institute · GBBritish Society for Antimicrobial Chemotherapy · GBNIHR Research Delivery Network · GBNorth Bristol NHS Trust · GB

Funding

Biotechnology and Biological Sciences Research CouncilChief Scientist OfficeDepartment of HealthMedical Research Council G1000803Medical Research Council MR/N029399/1Wellcome TrustWellcome Trust 089472Wellcome Trust 098051
6 · The paper itself

Abstract

Antibiotic resistance forms a serious threat to the health of hospitalised patients, rendering otherwise treatable bacterial infections potentially life-threatening. A thorough understanding of the mechanisms by which resistance spreads between patients in different hospitals is required in order to design effective control strategies. We measured the differences between bacterial populations of 52 hospitals in the United Kingdom and Ireland, using whole-genome sequences from 1085 MRSA clonal complex 22 isolates collected between 1998 and 2012. The genetic differences between bacterial populations were compared with the number of patients transferred between hospitals and their regional structure. The MRSA populations within single hospitals, regions and countries were genetically distinct from the rest of the bacterial population at each of these levels. Hospitals from the same patient referral regions showed more similar MRSA populations, as did hospitals sharing many patients. Furthermore, the bacterial populations from different time-periods within the same hospital were generally more similar to each other than contemporaneous bacterial populations from different hospitals. We conclude that, while a large part of the dispersal and expansion of MRSA takes place among patients seeking care in single hospitals, inter-hospital spread of resistant bacteria is by no means a rare occurrence. Hospitals are exposed to constant introductions of MRSA on a number of levels: (1) most MRSA is received from hospitals that directly transfer large numbers of patients, while (2) fewer introductions happen between regions or (3) across national borders, reflecting lower numbers of transferred patients. A joint coordinated control effort between hospitals, is therefore paramount for the national control of MRSA, antibiotic-resistant bacteria and other hospital-associated pathogens.

Indexed as

Drug Resistance, MicrobialStaphylococcal InfectionsGenetics, PopulationHospitalsHumansIrelandMethicillin-Resistant Staphylococcus aureusUnited Kingdomantimicrobial Resistancehospital networkMRSA

Identifiers

PMID29026654
PMCPMC5605955
OpenAlexW2727372147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.